[{"indications": "Indications\u00a0gout prophylaxis, hyperuricaemia", "name": "SULFINPYRAZONE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "10 Musculoskeletal and joint diseases", "10.1 Drugs used in rheumatic diseases and gout", "10.1.4 Gout and cytotoxic-induced hyperuricaemia", "Long-term control of gout", "SULFINPYRAZONE"], "cautions": "Cautions\u00a0see under Probenecid; regular blood counts advisable; cardiac disease (may cause salt and\r\nwater retention); interactions: Appendix 1 (sulfinpyrazone)", "side-effects": "Side-effects\u00a0gastro-intestinal disturbances, occasionally allergic\r\nskin reactions, salt and water retention; rarely blood disorders,\r\ngastro-intestinal ulceration and bleeding, acute renal failure, raised\r\nliver enzymes, jaundice and hepatitis", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/207431.htm", "doses": ["Initially 100\u2013200\u00a0mg daily with food (or milk) increasing\r\nover 2\u20133 weeks to 600\u00a0mg daily (rarely 800\u00a0mg daily), continued until\r\nserum uric acid concentration normal then reduced for maintenance\r\n(maintenance dose may be as low as 200\u00a0mg daily)"], "pregnancy": "Pregnancy\u00a0manufacturer advises caution\u2014no information available"}]